LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.86 | 21.74 | 2623 | 1887 | 1.3900 | 1.1049 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 29.86 | 21.74 | 2680 | 1887 | 1.4202 | 1.1120 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 31.83 | 21.74 | 1245 | 2110 | 0.5901 | 0.8464 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 31.83 | 21.74 | 2235 | 2110 | 1.0592 | 1.0175 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 31.83 | 21.74 | 2911 | 2110 | 1.3796 | 1.0999 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 31.83 | 21.74 | 2987 | 2110 | 1.4156 | 1.1081 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 33.80 | 21.74 | 1417 | 2381 | 0.5950 | 0.8525 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 33.80 | 21.74 | 2496 | 2381 | 1.0481 | 1.0139 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 33.80 | 21.74 | 3160 | 2381 | 1.3269 | 1.0853 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 33.80 | 21.74 | 3238 | 2381 | 1.3596 | 1.0928 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 35.77 | 21.74 | 1562 | 2602 | 0.6001 | 0.8574 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 35.77 | 21.74 | 2714 | 2602 | 1.0427 | 1.0122 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 35.77 | 21.74 | 3438 | 2602 | 1.3209 | 1.0823 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 35.77 | 21.74 | 3513 | 2602 | 1.3497 | 1.0888 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 37.74 | 21.74 | 1627 | 2828 | 0.5752 | 0.8486 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 37.74 | 21.74 | 3010 | 2828 | 1.0642 | 1.0178 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 37.74 | 21.74 | 3661 | 2828 | 1.2944 | 1.0748 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 37.74 | 21.74 | 3790 | 2828 | 1.3400 | 1.0851 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 39.71 | 21.74 | 1628 | 3084 | 0.5279 | 0.8290 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 39.71 | 21.74 | 3287 | 3084 | 1.0658 | 1.0179 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 39.71 | 21.74 | 4029 | 3084 | 1.3064 | 1.0762 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 39.71 | 21.74 | 4121 | 3084 | 1.3362 | 1.0828 | MN20160310_N01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.68 | 21.74 | 1846 | 3418 | 0.5400 | 0.8380 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.68 | 21.74 | 3666 | 3418 | 1.0723 | 1.0192 | MN20160310_N01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 41.68 | 21.74 | 4376 | 3418 | 1.2800 | 1.0688 | MN20160310_N01 | J07 |